Bank of New Hampshire’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MIH
MSR
PR
SO
WT
Bank of New Hampshire's XBI Position: Q2 2026 in Review
Bank of New Hampshire increased its State Street SPDR S&P Biotech ETF (XBI) stake by 10,750% in Q2 2026, buying an estimated $1.16M and bringing the position to 8,680 shares worth $1.37M. The position accounts for 0.29% of the portfolio, ranked #82.
Bank of New Hampshire first reported a position in XBI in Q2 2021 and has held it in 21 quarters since. 579 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Bank of New Hampshire held 8,680 shares of State Street SPDR S&P Biotech ETF worth $1.37M as of Q2 2026.
- Bank of New Hampshire bought 8,600 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.16M.
- State Street SPDR S&P Biotech ETF made up 0.29% of Bank of New Hampshire's portfolio in Q2 2026, its #82 holding.
- Bank of New Hampshire first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and has held it in 21 quarters since.
- 579 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.